T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells

Hematological Oncology

Volumn 15, Issue 4, 1997, Pages 197-207

  Schmitter, Doris ^a   Koss, Michael ^a   Niederer, Eva ^b   Stahel, Rolf Arno ^b   Pichert, Gabriella ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c Division of Oncology   (Switzerland)

Author keywords

CD40 pathway; Cytokines; Follicular lymphoma; T cells; Tonsillar GC B cells

Indexed keywords

ALPHA INTERFERON; CD40 ANTIGEN; CYTOKINE; DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; RECOMBINANT CYTOKINE; SCATTER FACTOR; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

3T3 CELLS; ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CD40 LIGAND; CELL DIVISION; CYTOKINES; HUMANS; LYMPHOMA, FOLLICULAR; MEMBRANE GLYCOPROTEINS; MICE; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0031401643     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(199711)15:4<197::AID-HON614>3.0.CO;2-V     Document Type: Article

References (39)

1. Defrance, T., Banchereau, J. Role of cytokines in the ontogeny, activation and proliferation of B-lymphocytes. In: Callard, R. E., ed. Cytokines and B Lymphocytes. London, U.K.: Academic Press, 1990: 65.
2. Clark, E., Ledbetter, J. A. How B and T cells talk to each other. Nature 1994, 367, 425-428.
3. Doerken, B., Moeller, P., Pezzutto, R., Moldenhauer, G. B-cell antigens: CD40. In: Knapp. W., Doerken, B., Gilks, W. R., et al., eds. Leucocyte Typing IV. White Cell Differentiation Antigens. Oxford, U.K.: Oxford University Press.
4. Uckun, F. M., Gajl-Peczalska, K., Myers, D. E., Jaszcz, W., Haissig, S., Ledbetter, J. A. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-cell lineage acute lymphoblastic leukemia as well as B-lineage Non-Hodgkin's lymphoma cells. Blood 1990, 76, 2449-2456.
5. Banchereau, J., De Paoli, P., Valle, A., Garcia, E., Rousset, F. Long term human B cell lines dependent on interleukin 4 and anti-CD40. Science 1991, 251, 70-72.
6. Johnson, P. W. M., Watt, S. M., Betts, D. R., et al. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 1993, 82, 1848-1857.
7. Rousset, F., Garcia, E., Banchereau, J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. Exptl. Med. 1991, 173, 705-710.
8. Pound, J. D., Gordon, J. Maintenance of human germinal center B cells in vitro. Blood 1997, 89(3), 919-928.
9. Rousset, F. E., Garcia, E., Peronne, P., De Paoli, P., Valle, A., Banchereau, J. Establishment of normal factor dependent human B-cell lines with anti-CD40 Mab and cytokines. J. Cell Biochem. 1990, 14D, 264-270.
10. Si, L., Roscoe, G., Whiteside, T. L. Selective distribution and quantilation of T-lymphocyte subsets in germinal centers of human tonsils. Arch. Pathol. Lab. Med. 1983, 107, 228-231.
11. Butch. A. W., Chung, G. H., Hoffman, J. W., Nahm, H. M. Cytokine expression by germinal center cells. J. Immunol. 1993, 150, 39-47.
12. Aderka, D., Maor, Y, Novick, D., et al. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells thal is induced by tumor necrosis factor α or β. Blood 1993, 81, 2076-2084.
13. Carlsson, M., Sundstrom, C., Bengtsson, M., Totterman, T. H., Rosen, A., Nilsson, K. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the costimulatory activation and progression signals. Eur. J. Immunol. 1989, 19,913-921.
14. Cordingley, F. T., Bianchi, A., Hoffbrand, A. V., et al. Tumour necrosis factor as an autocrine growth factor for chronic B-cell malignancies. Lancet 1988, 1, 969-1971.
15. Widmer, L., Pichert,. G., Jost, L. M., Stahel, R. A. Fate of contaminating t(14;18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells. Blood 1996, 88, 3166-3175.
16. Zwicky, C. S., Maddocks, A. B., Andersen, N., Gribben, J. G. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplaniation. Blood 1996, 88, 3314-3322.
17. Lee, J. S. Laboratory methods: Alternative dideoxy sequencing of double-stranded DNA by cyclic reactions using Taq polymerase. DNA Cell Biol. 1991, 10, 67-73.
18. Rabkin, C. S., Devesa, S. S., Zahm, S. H., Gail, H. M. Increasing incidence of Non Hodgkin's lymphomas. Sem. Hematol. 1993, 30, 286-296.
19. Braziel, R. M., Sussman, E., Jaflfe, E. S., Neckers, L. M.,. Cossman, J. Induction of immunoglobulin secretion in follicular Non Hodgkin's lymphomas: Role of immunoregulatory T cells. Blood 1985, 66, 128-134.
20. + cell clones. J. Immunol. 1990, 144, 2550-2557.
21. Jacob, M. Ch., Piccinni, M. P., Bonnefoix, Th., et al. T lymphocytes from invaded lymph nodes in patients with B-cell derived Non-Hodgkin's lymphoma: reactivity toward the malignant clone. Blood 1989, 75, 1154-1162.
22. Lane, P., Traunecker, A., Hubele, S., Inui, S., Lanzavechia, A., Gray, D. Activated human T cells express a ligand for the human B-cell associated antigen CD40 which participates in T-cell dependent activation of B lymphocytes. Eur. J. Immunol. 1992, 22, 2573-2578.
23. Funakoshi, S., Longo, D. L., Beckwith, M., et al. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 1994, 83, 2787-2794.
24. Banner, D. W., D'Arcy, A., Kanes, W., et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation. Cell 1993, 73, 431-436.
25. Mosmann, T. R., Coffmann, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7, 145-173.
26. Blay, J. Y., Burdin, N., Rousset, F., et al. Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor. Blood 1993, 82, 2169-2174.
27. Gazzinelli, R. T., Makino, M., Chattopadhyay, S. K., et al. CD4 subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus induced immunodeficiency in mice. J Immunol. 1992, 148, 198-205.
28. Tsuijmoto, Y., Finger, L. S., Yunis, P., Nowell, P. C., Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B-cells with the t(14;18) chromosome translocation. Science 1984, 226, 1097-1799.
29. McDonell, T. J., Deane. N., Platt, F. M., et al. Bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989, 57, 79-88.
30. H rearrangements in benign lymphoid tissue with follicular hyperplasia. Oncogene 1991, 6, 2271-2276.
31. Ersboll, J., Schultz, H. B., Pedersen-Bjergaard, J., Nissen, N. I. Follicular low-grade Non Hodgkin's lymphoma: long term outcome with or without tumor progression. Eur. J. Hematol. 1989, 42, 155-163.
32. Horning, S. J., Rosenberg, S. A. The natural history of initially untreated low grade Non Hodgkin's lymphomas. New Engl. J. Med. 1984, 311, 1471-1475.
33. Sporn, M. B., Roberts, A. B. Autocrine growth factors and cancer. Nature 1985, 313, 745-747.
34. Haas, R., Ho, A. D., Bredhauer, U., et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exptl. Hematol. 1990, 18, 94-98.
35. Ottman, O. G., Ganser, A., Seipelt, G., Eder. M., Schulz, G., Hoelzer, D. Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. Blood 1990, 76, 1494-1502.
36. Stahel, R. A., Jost, L. M., Cerny, Th., et al. A randomized study of recombinant human granulocyte colony stimulating factor (filgrastim) after high dose chemotherapy and autologous bone marrow transplantation for high risk lymphoid malignancies. J. Clin. Oncol. 1994, 12, 1931-1938.
37. Katsanis, E., Weisdorf. D. J., Xu, Z., Dancisak, B. B., Halet, M. L., Blaser, B. R. Infusions of interleukin-alpha after autologous or allogeneic bone marrow transplantation for Hodgkin's disease or Non-Hodgkin's lymphoma induce effector cells with anti-lymphoma activity. J. Clin. Immunol. 1994, 14, 205-211.
38. Soiffer, R. J., Murray, Ch., Gonin, R., Ritz, J. Effect of low-dose interleukin-2 on disease relapse after T-cell depleted allogeneic bone marrow transplantation. Blood 1994 84, 964-971.
39. Ganser, A., Lindemann, A., Seipelt, G., et al. Effects of recombinant interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood 1990, 76, 666-676.